Y-mAbs Therapeutics, Inc. (Nasdaq:YMAB)

Health Care/Life Sciences • Pharmaceuticals

CIK 1722964

Company

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Address
230 Park Avenue
Suite 3350
New York, New York 10169-0005

Employees
100

Stock Info

Close
$16.64

Day Range
16.34 - 17.29

52 Week Range
2.70 - 20.90

Average volume
380.6K

Short Interest
2.2M (02/15/24)

% of Float Shorted
6.66%

Market Cap
$758.66M

Revenue
$84.82M

Net Income
N/A

2020 Sales Growth
N/A

Rev. per Employee
$848.19K

P/E Ratio
N/A

EPS
-$0.49

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Michael Rossi

Vice Chairman & Chief Business Officer
Thomas Gad

Director
Mary A Tagliaferri MD

Chairman
James Irvin Healy MD, PhD

Independent Director
Laura J Hamill

Independent Director
Ashutosh Tyagi MD, MBA

Independent Director
David Neil Gill MBA, CPA

Independent Director
Gérard Ber PhD

Independent Director
Johan Ernst Wedell-Wedellsborg

SEC filings

Date	Form	Event
14 Nov, 2024	SC 13G/A
12 Nov, 2024	SC 13G/A
8 Nov, 2024	8-K
8 Nov, 2024	10-Q
4 Nov, 2024	SC 13G/A
4 Nov, 2024	8-K
15 Oct, 2024	UPLOAD
26 Sep, 2024	CORRESP
20 Sep, 2024	8-K
20 Sep, 2024	4
17 Sep, 2024	8-K
17 Sep, 2024	4
16 Sep, 2024	UPLOAD
13 Sep, 2024	144
3 Sep, 2024	144
30 Aug, 2024	4
28 Aug, 2024	144
27 Aug, 2024	4
26 Aug, 2024	144
12 Aug, 2024	8-K
12 Aug, 2024	10-Q
19 Jul, 2024	8-K
12 Jul, 2024	4
8 Jul, 2024	3
1 Jul, 2024	8-K
28 Jun, 2024	8-K
13 Jun, 2024	4
13 Jun, 2024	8-K
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
10 Jun, 2024	144
10 Jun, 2024	144
31 May, 2024	4
30 May, 2024	144
23 May, 2024	4
21 May, 2024	144
7 May, 2024	8-K
7 May, 2024	10-Q
29 Apr, 2024	ARS
29 Apr, 2024	DEF 14A
29 Apr, 2024	DEFA14A
29 Apr, 2024	8-K
8 Apr, 2024	SC 13G
14 Mar, 2024	4
14 Mar, 2024	8-K
8 Mar, 2024	3
7 Mar, 2024	4
7 Mar, 2024	4
7 Mar, 2024	4
6 Mar, 2024	144
6 Mar, 2024	144
5 Mar, 2024	144
4 Mar, 2024	8-K
29 Feb, 2024	8-K
29 Feb, 2024	S-8
29 Feb, 2024	10-K
14 Feb, 2024	SC 13G/A
14 Feb, 2024	4
13 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
6 Feb, 2024	SC 13G/A
26 Jan, 2024	SC 13G/A
22 Jan, 2024	4
22 Jan, 2024	4
22 Jan, 2024	4
22 Jan, 2024	4
22 Jan, 2024	4
22 Jan, 2024	4
22 Jan, 2024	4
9 Jan, 2024	8-K
26 Dec, 2023	4
15 Dec, 2023	4
13 Dec, 2023	144
12 Dec, 2023	4
12 Dec, 2023	4
11 Dec, 2023	4
11 Dec, 2023	4
1 Dec, 2023	4
1 Dec, 2023	4
29 Nov, 2023	4
29 Nov, 2023	4
22 Nov, 2023	4
20 Nov, 2023	144
13 Nov, 2023	8-K
13 Nov, 2023	10-Q
8 Nov, 2023	3
8 Nov, 2023	4
8 Nov, 2023	4
18 Oct, 2023	8-K
18 Oct, 2023	8-K	CEO Change
10 Aug, 2023	10-Q
10 Aug, 2023	8-K
9 Jun, 2023	4
9 Jun, 2023	4
9 Jun, 2023	4
9 Jun, 2023	4
9 Jun, 2023	4
9 Jun, 2023	4
9 Jun, 2023	8-K
26 May, 2023	8-K
23 May, 2023	8-K
17 May, 2023	4
17 May, 2023	4
8 May, 2023	10-Q
8 May, 2023	8-K
5 May, 2023	EFFECT
2 May, 2023	CORRESP
28 Apr, 2023	DEFA14A
28 Apr, 2023	ARS
28 Apr, 2023	DEF 14A
18 Apr, 2023	8-K
5 Apr, 2023	8-K
3 Apr, 2023	SC 13G
3 Apr, 2023	UPLOAD
30 Mar, 2023	S-3
30 Mar, 2023	8-K
30 Mar, 2023	S-8
30 Mar, 2023	10-K
13 Mar, 2023	8-K
14 Feb, 2023	SC 13G
14 Feb, 2023	SC 13G/A
9 Feb, 2023	SC 13G
2 Feb, 2023	8-K
1 Feb, 2023	SC 13G/A
30 Jan, 2023	4
30 Jan, 2023	4
30 Jan, 2023	4
30 Jan, 2023	4
30 Jan, 2023	4
19 Jan, 2023	4
19 Jan, 2023	4
19 Jan, 2023	4
19 Jan, 2023	4
19 Jan, 2023	4
19 Jan, 2023	4
19 Jan, 2023	4
4 Jan, 2023	8-K
21 Dec, 2022	8-K
16 Dec, 2022	8-K
14 Dec, 2022	8-K
8 Dec, 2022	8-K
2 Dec, 2022	8-K
16 Nov, 2022	4
7 Nov, 2022	10-Q
7 Nov, 2022	8-K
28 Oct, 2022	8-K
3 Oct, 2022	8-K
26 Sep, 2022	8-K	CEO Change
26 Sep, 2022	8-K
2 Sep, 2022	8-K
30 Aug, 2022	8-K
8 Aug, 2022	8-K
8 Aug, 2022	10-Q
19 Jul, 2022	4
19 Jul, 2022	4
19 Jul, 2022	4
19 Jul, 2022	4
19 Jul, 2022	4
19 Jul, 2022	4
12 Jul, 2022	8-K
13 Jun, 2022	8-K
2 Jun, 2022	8-K
31 May, 2022	8-K
26 May, 2022	8-K
19 May, 2022	4
19 May, 2022	8-K	CEO Change
9 May, 2022	8-K
9 May, 2022	10-Q
29 Apr, 2022	DEF 14A
29 Apr, 2022	DEFA14A
28 Apr, 2022	4
28 Apr, 2022	4
28 Apr, 2022	4
28 Apr, 2022	4
28 Apr, 2022	4
28 Apr, 2022	4
27 Apr, 2022	8-K	CEO Change
11 Apr, 2022	SC 13G/A
1 Apr, 2022	8-K
1 Mar, 2022	10-K
25 Feb, 2022	8-K
23 Feb, 2022	4
15 Feb, 2022	SC 13D/A
11 Feb, 2022	8-K
9 Feb, 2022	4
7 Feb, 2022	4
7 Feb, 2022	4
7 Feb, 2022	SC 13G/A
4 Feb, 2022	SC 13G/A
3 Feb, 2022	4
3 Feb, 2022	SC 13G/A
26 Jan, 2022	4
25 Jan, 2022	4
24 Jan, 2022	4
20 Jan, 2022	4
5 Jan, 2022	4
23 Dec, 2021	3
23 Dec, 2021	4
23 Dec, 2021	4
17 Dec, 2021	8-K
16 Dec, 2021	4
16 Dec, 2021	4
16 Dec, 2021	4
16 Dec, 2021	4
16 Dec, 2021	4
16 Dec, 2021	4
16 Dec, 2021	4
16 Dec, 2021	4
15 Dec, 2021	8-K
8 Dec, 2021	4
7 Dec, 2021	4
1 Dec, 2021	4
26 Nov, 2021	4
24 Nov, 2021	8-K
23 Nov, 2021	4
18 Nov, 2021	4
5 Nov, 2021	4
4 Nov, 2021	10-Q
4 Nov, 2021	8-K
4 Nov, 2021	8-K
1 Nov, 2021	4
26 Oct, 2021	4
19 Oct, 2021	4
7 Oct, 2021	8-K
5 Oct, 2021	4
4 Oct, 2021	4
23 Sep, 2021	4
17 Sep, 2021	4
13 Sep, 2021	8-K
8 Sep, 2021	4
7 Sep, 2021	4
24 Aug, 2021	4
17 Aug, 2021	4
13 Aug, 2021	4
9 Aug, 2021	10-Q
5 Aug, 2021	8-K
5 Aug, 2021	4
5 Aug, 2021	4
26 Jul, 2021	4
21 Jul, 2021	4
12 Jul, 2021	SC 13G/A
8 Jul, 2021	4
7 Jul, 2021	4
6 Jul, 2021	8-K
2 Jul, 2021	4
25 Jun, 2021	8-K
23 Jun, 2021	4
23 Jun, 2021	8-K
15 Jun, 2021	4
14 Jun, 2021	4
14 Jun, 2021	4
14 Jun, 2021	4
14 Jun, 2021	4
14 Jun, 2021	4
14 Jun, 2021	4
14 Jun, 2021	8-K
11 Jun, 2021	4
11 Jun, 2021	4
10 Jun, 2021	4
10 Jun, 2021	4
9 Jun, 2021	4
9 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
4 Jun, 2021	8-K
4 Jun, 2021	8-K
2 Jun, 2021	4
2 Jun, 2021	144
2 Jun, 2021	4
1 Jun, 2021	4
26 May, 2021	4
20 May, 2021	4
19 May, 2021	8-K
13 May, 2021	8-K
6 May, 2021	8-K
6 May, 2021	10-Q
28 Apr, 2021	DEF 14A
28 Apr, 2021	4
28 Apr, 2021	DEFA14A
27 Apr, 2021	8-K
20 Apr, 2021	8-K
14 Apr, 2021	4
12 Apr, 2021	8-K
5 Apr, 2021	4
17 Mar, 2021	4
12 Mar, 2021	4
12 Mar, 2021	4
3 Mar, 2021	4
1 Mar, 2021	10-K
25 Feb, 2021	8-K
22 Feb, 2021	8-K
19 Feb, 2021	8-K
18 Feb, 2021	4
18 Feb, 2021	424B5
17 Feb, 2021	424B5
12 Feb, 2021	SC 13G/A
4 Feb, 2021	SC 13G/A
3 Feb, 2021	4
2 Feb, 2021	SC 13G
22 Jan, 2021	8-K
21 Jan, 2021	4
20 Jan, 2021	4
7 Jan, 2021	4

Last update:2024-03-06 12:57:55.835644

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.